Postural Orthostatic tachycardia Syndrome Clinical Trials in Dallas, Texas
2 recruitingDallas, Texas
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
Postural Orthostatic Tachycardia Syndrome (POTS)
Regeneron Pharmaceuticals81 enrolled18 locationsNCT06593600
Recruiting
Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
Postural Orthostatic tachycardia Syndrome
University of Texas Southwestern Medical Center350 enrolled1 locationNCT06292104